Literature DB >> 13342513

VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow, and Wembley.

.   

Abstract

Entities:  

Keywords:  VACCINES AND VACCINATION; WHOOPING COUGH/prevention and control

Mesh：

Substances：

Year:  1956        PMID： 13342513      PMCID： PMC2034830     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Protective antigen of haemophilus pertussis.

Authors:  L PILLEMER; L BLUM; I H LEPOW
Journal:  Lancet       Date:  1954-06-19       Impact factor: 79.321

2.  The recognition of whooping-cough.

Authors:  D COURT; H JACKSON; G KNOX
Journal:  Lancet       Date:  1953-11-21       Impact factor: 79.321

3.  The inability of the capsular material of Haemophilus pertussis to produce protective antisera.

Authors:  D G EVANS; M O ADAMS
Journal:  J Gen Microbiol       Date:  1952-08

4.  Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium.

Authors:  S M Cohen; M W Wheeler
Journal:  Am J Public Health Nations Health       Date:  1946-04
  4 in total
  20 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.

Authors:  C M Ausiello; R Lande; F Urbani; A la Sala; P Stefanelli; S Salmaso; P Mastrantonio; A Cassone
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

3.  DEVELOPMENT OF PERTUSSIS VACCINE PRODUCTION AND CONTROL IN THE NATIONAL INSTITUTE OF PUBLIC HEALTH IN THE NETHERLANDS DURING THE YEARS 1950--1962.

Authors:  H H COHEN
Journal:  Antonie Van Leeuwenhoek       Date:  1963       Impact factor: 2.271

4.  A comparison between the intranasal and intracerebral infection of mice with Bordetella pertussis.

Authors:  A F Standfast; J M Dolby
Journal:  J Hyg (Lond)       Date:  1961-06

5.  Relationship of immunogenicity to protective potency in acellular pertussis vaccines.

Authors:  Dorothy Xing; Catpagavalli Asokanathan; Ying Hua Xu; Barbara Bolgiano; Alex Douglas-Bardsley; Shumin Zhang; Junzhi Wang; Michael Corbel
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.

Authors:  J M Dolby; D E Dolby
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.

Authors:  Michael P Fay; Dean A Follmann; Freyja Lynn; Jarad M Schiffer; Gregory V Stark; Robert Kohberger; Conrad P Quinn; Edwin O Nuzum
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

9.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.

Authors:  Yinghua Xu; Yaying Wang; Yajun Tan; Huajie Zhang; Lijie Wu; Lichan Wang; Qiming Hou; Shumin Zhang
Journal:  BMC Microbiol       Date:  2009-12-29       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.